Author:
Garcia-Caballero M.,Neugebauer E.,Rodriguez F.,Nuñez de Castro I.,Heredia A.,Oosting E.,Vara Thorbeck C.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference11 articles.
1. J. Bartholeyns and M. Bouclier,Involvement of histamine in growth of mouse and rat tumours: Antitumoural properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res.44, 639–645 (1984).
2. C. Burtin, P. Scheinmann, J. C. Salomon, G. Lespinats, F. Loisillier and P. Canu,The influence of intraperitoneal injections of histamine on tumour growth in fibrosarcoma-bearing mice. Cancer Lett.12, 195–201 (1981).
3. C. Burtin, P. Scheinmann, J. C. Salomon, G. Lespinats and P. Canu,Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H 1 and H 2 histamine receptors. Br. J. Cancer45, 54–60 (1982).
4. J. Bartholeyns and J. R. Fozard,Role of histamine in tumour development. Trends pharmacol. Sci.6, 123–125 (1985).
5. C. Burtin, C. Noiret, P. Scheinmann, L. Galoppin, D. Sabolovic and P. Bernard,Clinical improvement in advanced cancer disease after treatment combining histamine and H 2-antihistamines (ranitidine or cimetidine). Eur. J. Cancer. clin. Oncol.24, 161–167 (1988).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献